| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/25/2009 | EP1377579B1 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 03/25/2009 | EP1319183B1 Methods and products related to low molecular weight heparin |
| 03/25/2009 | EP1299421B1 Antibodies to human mcp-1 |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | EP1238282B1 Methods of diagnosis and treatment by binding p75/airm1 |
| 03/25/2009 | EP1221847B1 Methods of enhancing chemotherapy |
| 03/25/2009 | EP0960197B1 GENES FROM 20q13 AMPLICON AND THEIR USES |
| 03/25/2009 | CN101395228A Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof |
| 03/25/2009 | CN101395183A Anti-ephb4 antibodies and methods using same |
| 03/25/2009 | CN101395171A Steroidal compounds as steroid sulphatase inhibitors |
| 03/25/2009 | CN101395166A Compounds and methods for the treatment of cancer |
| 03/25/2009 | CN101395155A Pyridopyrimidinone inhibitors of pi3k alpha |
| 03/25/2009 | CN101394857A Composite for treating cancer containing oligonucleotide and nontoxic LPS |
| 03/25/2009 | CN101392262A Polypeptide of fungal ubuquitin-conjugating enzyme, coding sequence thereof and preparation method and application |
| 03/25/2009 | CN101392030A Middle substitution degree carboxymethyl pachyman, preparation method thereof and use thereof |
| 03/25/2009 | CN101392026A Polypeptide for preventing and treating fibrotic disease and liver cancer |
| 03/25/2009 | CN101392015A Triterpene saponin in camellia seeds, preparation method and medical use thereof |
| 03/25/2009 | CN101392013A Ginsenoside Rb1 containing impurity ginsenoside Rh1 |
| 03/25/2009 | CN101392010A Shikonin carbohydrate derivatives and synthetic method and use thereof |
| 03/25/2009 | CN101392007A Anti-tumor manganese complexes using mitochondria as target point and preparation and use thereof |
| 03/25/2009 | CN101391995A Water-soluble paclitaxel ester compounds containing 1,2,3-triazole and preparation method |
| 03/25/2009 | CN101391989A Method for preparing polyhydroxy taxone and paclitaxel |
| 03/25/2009 | CN101391961A Phyllanthus emblica leaf or fruit anticancer Chinese medicine and preparation method and use thereof |
| 03/25/2009 | CN101391104A New use of oncolytic adenovirus recombinant of tumour cell single-expression immunoloregulation fator GM-CSF |
| 03/25/2009 | CN101391098A Apitoxin liposome preparation and preparation method thereof |
| 03/25/2009 | CN101391097A Special short-chain peptide cancer therapeutical agent and use thereof in treating cancer |
| 03/25/2009 | CN101391096A Use of Staphylococcal Enterotoxin. C in preparing anti-tumor medicine |
| 03/25/2009 | CN101391074A Medicine composition for treating digestive system carcinoma and preparation method thereof |
| 03/25/2009 | CN101391070A Quality control method of traditional Chinese medicine composition with anti-tumor action |
| 03/25/2009 | CN101391056A Medicine for treating aplastic anemia |
| 03/25/2009 | CN101391043A Traditional Chinese medicine polysaccharide extract for suppressing lung cancer A549 cell proliferation and preparation method thereof |
| 03/25/2009 | CN101391042A Traditional Chinese medicine extract for suppressing lung cancer A549 cell proliferation and preparation method thereof |
| 03/25/2009 | CN101391038A Traditional Chinese medicine formulation for treating transitional cell carcinomal of bladder |
| 03/25/2009 | CN101391036A Medicine composition for treating lung cancer |
| 03/25/2009 | CN101391019A Internal medicine for treating breast carcinoma |
| 03/25/2009 | CN101391006A Medicine composition for treating tumor and preparation method thereof |
| 03/25/2009 | CN101391004A Medicine composition for treating late-stage esophageal carcinoma |
| 03/25/2009 | CN101390979A Raisin tree seed extract and preparation method and use thereof in preparing anti-tumor medicine |
| 03/25/2009 | CN101390919A Use of pepperweed seed extract in preparing anti-tumor medicine |
| 03/25/2009 | CN101390871A Ginsenoside Rb1 containing impurity ginsenoside Rd |
| 03/25/2009 | CN101390870A Ginsenoside Rb1 containing impurity ginsenoside Rc |
| 03/25/2009 | CN101390867A Compositions and methods for the treatment of infection |
| 03/25/2009 | CN101390865A Anticancer composition containing lurtolecan |
| 03/25/2009 | CN101390858A Loperamide hydrochloride as antineoplastic component and uses thereof |
| 03/25/2009 | CN101390833A Anti-cancer slow-release formulation loaded with carmustine and synergist thereof |
| 03/25/2009 | CN101390832A Anti-cancer slow-release formulation loaded with carmustine and fluorouracil |
| 03/25/2009 | CN101390831A Docetaxel medical composition for injection and preparation method thereof |
| 03/25/2009 | CN101390829A Anticancer composition loaded with anti-metabolism medicine fluorouracil and synergist thereof |
| 03/25/2009 | CN101390828A Anticancer composition loaded with anti-metabolism medicine and synergist thereof |
| 03/25/2009 | CN101390827A Sustained-release injection containing methotrexate synergist |
| 03/25/2009 | CN101390826A Magnetic tumour target polymer nano vesicle and preparation method thereof |
| 03/25/2009 | CN100472213C Detection and treatment of cancer |
| 03/25/2009 | CN100471957C Adenovirus vectors for immunotherapy |
| 03/25/2009 | CN100471948C Composition of antibody specifically binding to CD20 |
| 03/25/2009 | CN100471873C A series of polypeptide capable of blocking IL-6 |
| 03/25/2009 | CN100471872C Optimizing fusion protein containing VEGF recerver segment and medical application thereof |
| 03/25/2009 | CN100471871C Therapeutic human anti-IL-1R1 monoclonal antibody |
| 03/25/2009 | CN100471869C Preparation and assaying of peptide dextran possessing detectable oral absorption immune regulation of coriolus versicolor |
| 03/25/2009 | CN100471868C Compositions and methods for WT1 specific immunotherapy |
| 03/25/2009 | CN100471862C Antisense oligonucleotides that inhibit expression of HIF-1 |
| 03/25/2009 | CN100471853C Phenyl-thiophene type vitamin D receptor modulators |
| 03/25/2009 | CN100471847C Eremophilane containing chlorine atom in Heizituowu and its anti-biotic and cell-toxin activity |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/25/2009 | CN100471515C Natural anticancer preparation and process and use thereof |
| 03/25/2009 | CN100471513C Medicinal formulation for treating cancer and preparation method thereof |
| 03/25/2009 | CN100471496C Inclusion containing raltitrexed and its powder injection |
| 03/25/2009 | CN100471493C Liposome preparation containing Oxaliplatin |
| 03/25/2009 | CN100471492C Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 03/25/2009 | CN100471491C Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 03/25/2009 | CN100471490C Sesquiterpene ketone injection, preparing method and use thereof |
| 03/24/2009 | US7507872 Transgenic toll-like receptor 9 (TLR9) mice |
| 03/24/2009 | US7507831 Therapy for breast cancer; plant extracts; 4-[(2-benzothiazolyl)thio]-5,7,3',4'-tetra-O-benzyl-epicatechin, 4-[(2-benzothiazolyl)thio]-5,7,3',4'-tetra-O-benzyl-catechin, 4-[(2-benzothiazolyl)thio]-3-O-acetyl-5,7,3',4'-tetra-O-benzyl-epicatechin |
| 03/24/2009 | US7507807 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 03/24/2009 | US7507805 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507765 Mevalonic acid derivatives; antitumor/anticancer agents |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507759 Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione |
| 03/24/2009 | US7507749 Antitumor agents |
| 03/24/2009 | US7507741 Heterocyclic compounds |
| 03/24/2009 | US7507740 Fused heterocyclic compound |
| 03/24/2009 | US7507739 Against tumors expressing multiple drug resistance by promoting microtubule polymerization; deesterification of a phenyldiester with 3-amino-1,2,4-triazole, halogenation with a phosphorusoxyhalide, amination with a perfluoroalkylamine in the presence of a strong base and aprotic solvent |
| 03/24/2009 | US7507734 Pyridazinone derivatives |
| 03/24/2009 | US7507712 NOV protein: an anti-angiogenic agent and its use, in particular for the treatment of cancer |
| 03/24/2009 | US7507705 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 03/24/2009 | US7507542 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 03/24/2009 | US7507541 36P6D5: secreted tumor antigen |
| 03/24/2009 | US7507537 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/24/2009 | US7507529 genetic amplification of a target nucleic acid in biological samples containing primate T-lymphotropic viruses (PTLVs), include human and simian T-lymphotropic viruses (HTLV and STLV), and detecting the strain of PTLV contained in the sample by determining nucleotide fragments that have been amplified |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507410 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof |
| 03/24/2009 | US7507407 Immunoliposomes that optimize internationalization into target cells |
| 03/24/2009 | US7507403 drugs comprising an isolated protein, mixed with pharmaceutically acceptable carriers, excipients or diluents, used as an immunogenic composition for stimulating or enhancing the production of antibodies directed against the protein |
| 03/24/2009 | CA2520979C Formulations of ecteinascidins |
| 03/24/2009 | CA2450690C Improved chelator conjugates |
| 03/24/2009 | CA2431100C Dihydroindole and tetrahydroquinoline derivatives |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2382404C Tricyclic inhibitors of poly(adp-ribose) polymerases |